There are 2789 resources available
419P - XELOX/XELIRI alternative regimen as first-line treatment of metastatic colorectal cancer (CCRCTO-2: TROT): A phase II study
Presenter: YU HAN
Session: ePoster Display
420P - A single-arm, multicenter, phase II study of anlotinib combined with CAPEOX as first-line treatment in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ALTER-C002)
Presenter: Kefeng Ding
Session: ePoster Display
421P - FOLFIRINOX with or without targeted therapy as first line for metastatic colorectal cancer: An AGEO multicenter real-world study
Presenter: Romain Varnier
Session: ePoster Display
422P - The efficacy and safety of irinotecan plus raltitrexed as second-line treatment in advanced colorectal cancer (ACC) patients: A summary analysis of a multicenter, phase II trial
Presenter: Xiujuan Qu
Session: ePoster Display
423P - From clinical trial to bedside: Triplet chemotherapy (FOLFOXIRI-B) in metastatic colorectal cancer
Presenter: Guus Bol
Session: ePoster Display
362P - Influence of the expression of ABCG2 transporters on the results of photodynamic therapy in malignant gliomas
Presenter: Artemii Rynda
Session: ePoster Display
363P - Clinical significance of telomerase reverse transcriptase (TERT) promoter mutations, telomere length and MGMT promoter methylation status in newly diagnosed and recurrent IDHwildtype glioblastoma (GBM) patients (PTS): A large mono-institutional study
Presenter: Giuseppe Lombardi
Session: ePoster Display
364P - Implementation of a comprehensive streamlined next generation sequencing (NGS) test for glioma including detection of the 1p/19q codeletion
Presenter: Sian Wood
Session: ePoster Display
365P - The analysis of FGFR-gene family alterations in glioma
Presenter: yunqian Li
Session: ePoster Display